Irisin is associated with physical activity level and hepatic steatosis grade in non-alcoholic fatty liver disease subjects

被引：0
|
作者：
So, Rina [1 ,2 ]
Oh, Sechang [3 ]
Shida, Takashi [3 ]
Tanaka, Kiyoji [1 ]
Shoda, Junichi [3 ]
机构：
[1] Univ Tsukuba, Tsukuba, Ibaraki, Japan
[2] Japan Soc Promot Sci, Tsukuba, Ibaraki, Japan
[3] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
841
引用
收藏
页码：606A / 606A
页数：1
相关论文
共 50 条
  • [21] Hepatic fibrosis - and not steatosis - is the main determinant of arterial stiffness in non-alcoholic fatty liver disease
    Yilmaz, Yusuf
    Eren, Fatih
    ATHEROSCLEROSIS, 2019, 290 : 222 - 223
  • [22] Dihydrosphingolipids are associated with steatosis and increased fibrosis damage in non-alcoholic fatty liver disease
    Babiy, Bohdan
    Ramos-Molina, Bruno
    Ocana, Luis
    Sacristan, Silvia
    Burgos-Santamaria, Diego
    Martinez-Botas, Javier
    Busto, Rebeca
    Perna, Cristian
    Frutos, M. Dolores
    Albillos, Agustin
    Pastor, Oscar
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS, 2023, 1868 (07):
  • [23] Fatty liver index and hepatic steatosis index for prediction of non-alcoholic fatty liver disease in type 1 diabetes
    Sviklane, Laura
    Olmane, Evija
    Dzerve, Zane
    Kupcs, Karlis
    Pirags, Valdis
    Sokolovska, Jelizaveta
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 (01) : 270 - 276
  • [24] NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) IS ASSOCIATED WITH LOW LEVEL OF PHYSICAL ACTIVITY: A POPULATION-BASED STUDY
    Mishra, A.
    Otgonsuren, M.
    Stepanova, M.
    Esceik, C.
    Gerber, L.
    Younossi, Z. M.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S524 - S525
  • [25] Thyroid function is associated with non-alcoholic fatty liver disease in euthyroid subjects
    Tao, Yang
    Gu, Hongbing
    Wu, Jingcheng
    Sui, Jian
    ENDOCRINE RESEARCH, 2015, 40 (02) : 74 - 78
  • [26] Non-alcoholic fatty liver disease (NAFLD) is associated with low level of physical activity: a population-based study
    Gerber, L.
    Otgonsuren, M.
    Mishra, A.
    Escheik, C.
    Birerdinc, A.
    Stepanova, M.
    Younossi, Z. M.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2012, 36 (08) : 772 - 781
  • [27] PHYSICAL ACTIVITY REDUCE HEPATIC APOPTOSIS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE AND VISCERAL OBESITY
    Dynnyk, N.
    Svintsitsky, A.
    Solovyova, G.
    Bogomaz, V.
    Baka, O.
    Gurbych, O.
    Golovchanska, Y.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S491 - S491
  • [28] Hepatic steatosis and non-alcoholic fatty liver disease are not associated with decline in renal function in people with Type 2 diabetes
    Jenks, S. J.
    Conway, B. R.
    Hor, T. J.
    Williamson, R. M.
    McLachlan, S.
    Robertson, C.
    Morling, J. R.
    Strachan, M. W. J.
    Price, J. F.
    DIABETIC MEDICINE, 2014, 31 (09) : 1039 - 1046
  • [29] Controlled Attenuation Parameter (CAP) for the detection of hepatic steatosis in alcoholic liver disease (ALD) and non-alcoholic fatty liver disease (NAFLD)
    Naveau, Sylvie
    Perlemuter, Gabriel
    Ziol, Marianne
    Carmona, Damien
    Trinchet, Jean Claude
    Prevot, Sophie
    Nohra, Pascal
    Nguefang-Njike, Micheline Nakseu
    Beaugrand, Michel
    HEPATOLOGY, 2012, 56 : 898A - 898A
  • [30] Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease
    Kan, Hiromi
    Kimura, Yuki
    Hyogo, Hideyuki
    Fukuhara, Takayuki
    Fujino, Hatsue
    Naeshiro, Noriaki
    Honda, Yohji
    Kawaoka, Tomokazu
    Tsuge, Masataka
    Hiramatsu, Akira
    Imamura, Michio
    Kawakami, Yoshiiku
    Aikata, Hiroshi
    Ochi, Hidenori
    Arihiro, Koji
    Chayama, Kazuaki
    HEPATOLOGY RESEARCH, 2014, 44 (14) : E420 - E427
12345